News

The Centers for Disease Control and Prevention updated requirements for health care providers participating in the COVID-19 Vaccination Program to clarify that participants may not sell or divert COVID-19 vaccine or ancillary materials purchased for the program; reproduce the program’s COVID-19 vaccination record cards without written permission from CDC; or use or disclose data collected from vaccine recipients for commercial marketing or other prohibited purposes. 

The United States Supreme Court rejected the third major challenge to the Affordable Care Act, holding in a 7-2 decision that the challengers did not have “standing,” or the legal right to challenge the portions of the ACA they alleged were unconstitutional.

On this AHA Advancing Health podcast, Leon Caldwell, AHA’s senior director of health equity strategies and innovation, talks with Keith Ellison, program director of the Urban League of Philadelphia Entrepreneurship Center, about how the COVID-19 pandemic highlighted the pivotal role local businesses play in advancing equitable health outcomes, as well as the challenges and opportunities they face during the road to recovery.

A National Institutes of Health-led review of more than 24,000 stored blood samples suggests that the coronavirus that causes COVID-19 was present in the U.S. as far back as December 2019.

The Food and Drug Administration authorized for emergency use one more batch of drug substance manufactured for the Janssen (Johnson & Johnson) COVID-19 vaccine at an Emergent BioSolutions facility in Baltimore.

Rhode Island health care providers may no longer order the monoclonal antibodies bamlanivimab and etesevimab until further notice due to rising prevalence of the SARS-CoV-2 P.1 and B.1.351 variants, which are not susceptible to the combination therapy, the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response announced.

The Medicare Payment Advisory Commission issued its June report to Congress on refinements to Medicare payment systems and issues affecting the Medicare program, which includes recommendations approved by the commission in April.

Moderna Inc. announced an agreement with the U.S. government for the purchase of an additional 200 million doses of Moderna’s COVID-19 vaccine, along with an option to purchase other COVID-19 vaccine candidates in the biotech company’s development pipeline.

As requested by the AHA, the Centers for Medicare & Medicaid Services said it will continue to remain flexible in its approach to surveys if a hospital experiences a COVID-19 surge.

In this AHA blog Priya Bathija, vice president of strategic initiatives, and Elisa Arespacochaga, vice president of clinical affairs and workforce, share five ways to improve collaborations between administrative and clinical leaders when designing and implementing value-based strategies.

The Centers for Disease Control and Prevention released a COVID-19 Viral Testing Tool to help health care providers and individuals understand their COVID-19 testing options and take appropriate next steps.

Only 11% of pregnant women in the Centers for Disease Control and Prevention’s Vaccine Safety Datalink, which includes vaccine safety monitoring data from nine integrated health systems, were fully vaccinated against COVID-19 by May 8, compared with 25% of non-pregnant women, the CDC reported.

A coalition of 13 health care organizations, including the AHA, voiced support for the Accountable Care in Rural America Act, bipartisan legislation that would revise the benchmarking formula for the Medicare Shared Savings Program to ensure participating accountable care organizations have an equal opportunity to share in savings regardless of their geographic location.

During the COVID-19 pandemic, Milwaukee-based Advocate Aurora Health used its broad resources to ensure adequate supplies and equipment, develop a flexible staffing strategy, create surge predictive models and increase operational efficiencies.

The Senate Finance Committee held a hearing to examine how to improve access to mental health and substance use disorder treatment and address inequities. 

More than 1 million Americans selecting a 2021 health plan through the federally facilitated marketplace since April 1 will pay $10 or less per month, the Centers for Medicare & Medicaid Services announced.

The Health Resources and Services Administration awarded 14 organizations grants to hire people to support COVID-19 vaccination and outreach in vulnerable and medically underserved communities.

The Food and Drug Administration added sodium citrate tubes used to collect blood specimens to its device shortage list and recommended health care providers only use the tubes when medically necessary, among other conservation strategies.  

The Food and Drug Administration Friday authorized for emergency use two batches of drug substance manufactured for the Janssen (Johnson & Johnson) COVID-19 vaccine at an Emergent BioSolutions facility in Baltimore.

Novavax announced phase 3 trial results for its COVID-19 vaccine, saying it provides 100% protection against moderate and severe disease, with a 90.4% overall efficacy.